Laddar...

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars

The monoclonal antibody trastuzumab (Herceptin®), which targets the human epidermal growth factor receptor 2 (HER2), is approved for the treatment of early breast and advanced breast and gastric cancer in which HER2 is overexpressed. Several biosimilar versions of trastuzumab are expected to enter t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Br J Cancer
Huvudupphovsmän: Barbier, Liese, Declerck, Paul, Simoens, Steven, Neven, Patrick, Vulto, Arnold G., Huys, Isabelle
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2019
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738325/
https://ncbi.nlm.nih.gov/pubmed/31257362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0480-z
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!